Jasper Ridge Partners’s Edwards Lifesciences EW Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$9.5M Hold
105,000
0.2% 32
2026
Q1
$8.41M Hold
105,000
0.19% 31
2025
Q4
$8.95M Hold
105,000
0.2% 32
2025
Q3
$8.17M Hold
105,000
0.18% 39
2025
Q2
$8.21M Hold
105,000
0.21% 37
2025
Q1
$7.61M Hold
105,000
0.24% 35
2024
Q4
$7.77M Hold
105,000
0.25% 36
2024
Q3
$6.93M Hold
105,000
0.2% 42
2024
Q2
$9.7M Hold
105,000
0.31% 33
2024
Q1
$10M Hold
105,000
0.32% 38
2023
Q4
$8.01M Hold
105,000
0.32% 30
2023
Q3
$7.27M Hold
105,000
0.34% 29
2023
Q2
$9.9M Hold
105,000
0.5% 27
2023
Q1
$8.69M Hold
105,000
0.41% 27
2022
Q4
$7.83M Hold
105,000
0.47% 25
2022
Q3
$8.68M Hold
105,000
0.58% 26
2022
Q2
$9.98M Hold
105,000
0.6% 24
2022
Q1
$12.4M Hold
105,000
0.61% 25
2021
Q4
$13.6M Hold
105,000
0.51% 27
2021
Q3
$11.9M Hold
105,000
0.53% 31
2021
Q2
$10.9M Hold
105,000
0.54% 30
2021
Q1
$8.78M Hold
105,000
0.4% 28
2020
Q4
$9.58M Hold
105,000
0.42% 28
2020
Q3
$8.38M Buy
+105,000
New +$8.19M 0.48% 29

Other funds holding EW

Jasper Ridge Partners's EW Position: Q2 2026 in Review

Jasper Ridge Partners held its Edwards Lifesciences (EW) position steady in Q2 2026 at 105,000 shares worth $9.5M. The position accounts for 0.2% of the portfolio, ranked #32.

Jasper Ridge Partners first reported a position in EW in Q3 2020 and has held it in 24 quarters since. The position peaked at $13.6M in Q4 2021. 1,330 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Jasper Ridge Partners held 105,000 shares of Edwards Lifesciences worth $9.5M as of Q2 2026.
  • Jasper Ridge Partners left its Edwards Lifesciences share count unchanged in Q2 2026.
  • Edwards Lifesciences made up 0.2% of Jasper Ridge Partners's portfolio in Q2 2026, its #32 holding.
  • Jasper Ridge Partners first reported a position in Edwards Lifesciences in Q3 2020 and has held it in 24 quarters since.
  • Jasper Ridge Partners's Edwards Lifesciences position peaked at $13.6M in Q4 2021.
  • 1,330 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Jasper Ridge Partners's 13F filing for Q2 2026, filed 13 Aug 2026.